The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)

NCT01832103 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency

Interventions

DRUG: MK-7145

Sponsor

Merck Sharp & Dohme LLC